Rousselot, Darling Ingredients’ premier collagen and gelatin brand, will spotlight its science-backed collagen solutions at Vitafoods Europe 2026 (stand 3C146), with an exclusive introduction to its new science on targeted collagen peptides for next-generation metabolic support and glucose control. The company will also present its wider collagen and gelatin portfolio supporting holistic wellbeing and healthier reformulation.
As GLP-1 therapies shake up the nutrition and supplement landscape, Rousselot will spotlight Nextida® GC, a next-generation collagen peptide composition designed to help manage post-meal glucose levels and enhance the body’s natural GLP-1 response.[1] Alongside the opportunity to explore application concepts tailored for trending and emerging consumer needs such as glucose support, joint support, wellbeing and beauty, visitors can learn from Rousselot experts about the new study into Nextida® GC. The study not only corroborated findings on natural GLP-1 secretion enhancement but also demonstrated lowered post-meal glucose spikes and improved insulin response, showing significant delayed gastric emptying, another mechanism which contributes to preventing spikes in blood sugar after eating.[2]
“Innovation in metabolic support must be grounded in strong science,” said Lauretta Katsriku, Global Category Leader (H&N) – Collagen at Rousselot. “Our work doesn’t stop at launching an ingredient. We remain committed to ongoing research and investment to continuously strengthen the scientific foundation behind Nextida® GC, helping our partners bring credible, evidence-based metabolic support solutions to market.”

At Vitafoods Europe 2026, visitors can gain in-depth scientific and market insights during two expert-led sessions from Rousselot:
Nextida® GC: The newest science behind its metabolic balance benefits. This session will present the latest findings on Nextida® GC, including its mechanism of action and the key consumer personas positioned to benefit from natural metabolic support.
- Speaker: Dr. Catarina Silva
- Date: Tuesday, 5 May
- Time: 14:30–14:55
- Theatre: New Ingredients Theatre (3D258)
Innovating GLP-1 Companions: collagen-based solutions, from protein boost to side-effect support. This session will highlight how premium collagen ingredients such as Peptan® can strengthen companion nutrition solutions to increase protein intake and even support in side effect mitigation and how Rousselot’s collagen portfolio enables versatile, evidence-based concepts across categories.
- Speakers: Lauretta Katsriku and Tim de Lange
- Date: Wednesday, 6 May
- Time: 14:30–14:55
- Theatre: New Ingredients Theatre (3D258)
A complete portfolio for in demand health areas
Beyond Nextida® GC, Rousselot will showcase: Peptan®, a premium collagen peptide for holistic wellbeing, supporting beauty[3], mobility[4] and active lifestyles[5], Colartix®, a hydrolyzed cartilage collagen matrix for joint health applications as well as Protake® and Peptinex®, collagen protein solutions designed for enriched nutritional formulations. The company will also present high-quality gelatin solutions for functional gummies, softgels and hard capsules, combining technical performance with formulation flexibility.
To understand how these ingredients can be enjoyed in every-day routines, visitors will also be able to explore a range of applications, including cold beverages and mocktails on the stand:
- -- Nextida® GC shots in tropical flavors for convenient metabolic support.
- -- New Peptan® flavored sachets (e.g., cucumber-mint-lime), offering premium solubility and neutral taste for flavor innovation.
- -- Colartix® gummies delivering joint support in indulgent confectionery formats.
- -- Peptan® concepts in refreshing beverage applications, including carbonated soda-style drinks.
To discover the latest innovations in collagen and gelatin solutions, visit stand 3C146 at Vitafoods Europe 2026. For more information, visit https://www.darlingii.com/rousselot.
[1] Grasset, et al. A Specific Collagen Hydrolysate Improves Postprandial Glucose Tolerance in Normoglycemic and Prediabetic Mice and in a First Proof of Concept Study in Healthy, Normoglycemic and Prediabetic Humans. Food Sci Nutr, 12: 9607-9620, 2024. https://doi.org/10.1002/fsn3.4538
[2] Rousselot study, 2025
[3] Asserin, J., et al. The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo-controlled clinical trials. Journal of Cosmetic Dermatology. 2015. https://doi.org/10.1111/jocd.12174
[4] Dar et al. Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis. PLoS ONE 12(4) (2017).
[5] Clifford et al. The effects of collagen peptides on muscle damage, inflammation and bone turnover following exercise: a randomized, controlled trial. Amino Acids 51, 691–704 (2019). https://doi.org/10.1007/s00726-019-02706-5

Login/Register
Supplier Login
















